Pharmaceutical Litigation Experience

Baum, Hedlund, Aristei & Goldman has extensive experience in litigating drug injury, wrongful death and consumer class action cases against major pharmaceutical companies for more than 30 years.

Our firm has been representing victims of defective drugs since the late 1980s. We started handling SSRI (selective serotonin reuptake inhibitors) antidepressant drug injury cases in 1990 and we were appointed to the Plaintiffs’ Steering Committee in the early 1990s in the first SSRI-suicide litigation involving Prozac (the first SSRI approved by the FDA for marketing in the U.S.).

Our firm’s drug product liability litigation department has handled thousands of individual prescription drug and consumer product injury or death cases against pharmaceutical defendants such as A.H. Robins Company, Alpha Therapeutic, Armour Pharmaceutical Co., Baxter Health Care Corp, Bayer Corp,  Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline, Merck, Pfizer, Sanofi, Takeda, and Wyeth.

Our litigation team is presently focusing on consumer products and prescription drug personal injury and wrongful death cases involving:

The team of lawyers working on our pharmaceutical defect cases has an in depth understanding of biomedical research, clinical trials, statistics, the pharmaceutical industry and marketing, as well as successful and effective discovery procedures and extensive work with experts on complicated scientific issues because of their years of experience related to Baum Hedlund’s past pharmaceutical litigation.

Our firm has developed a reputation as a law firm that can be counted upon to go above and beyond what is needed to get the job done; a firm that has successfully litigated drug injury, wrongful death and consumer fraud cases against major pharmaceutical companies. We maintain the highest *AV® peer review legal rating and are recognized as a preeminent plaintiff firm that tries or settles serious personal injury and wrongful death lawsuits across the nation.

While representing our clients, we dig deep into drug company files to discover the truth about what the company knew about the drug’s risks, when the company knew of those risks and what efforts, if any, the company took to hide those risks. Only through legal action can anyone gain access to this type of information.

Our lawyers are also strong public health advocates. Baum Hedlund attorneys have testified on several occasions at FDA drug safety hearings and have met with several members of the U.S. House and Senate. Many of our attorneys have delivered Continuing Legal Education accredited lectures and written articles on the many complex issues involved in pharmaceutical litigation. Our law firm has also assisted investigators in a number of Congressional investigations.

Past efforts by Baum Hedlund and others have resulted in improvements in drug safety including the FDA black box suicide warning issued on certain antidepressants. The firm’s efforts get innocent victims compensated when duties are neglected or willfully disregarded.

Baum Hedlund has been on the prevailing side of some of the nation’s most highly-publicized cases. Such litigation involves complex evidence and choice of law issues which have been routinely handled by the firm in both state and federal courts. Many of our attorneys have delivered Continuing Legal Education accredited lectures and written articles on the many complex issues involved in pharmaceutical litigation. Baum Hedlund is accustomed to handling the simplest and most complex cases and is here to solve legal problems caused by negligent conduct.

Over the past two decades, Baum Hedlund has been handling SSRI-induced suicide/violence litigation involving Prozac, Paxil and Zoloft. The firm is also representing families in SSRI related PPHN, heart birth defect and autism cases. We have the longest track-record handling SSRI antidepressant litigation, having litigated thousands of antidepressant cases. Baum Hedlund was appointed Lead Counsel for the Plaintiffs’ Steering Committee (MDL-1574) Paxil Products Liability Litigation and has been on the plaintiffs steering committees on a number of other pharmaceutical multi-district litigation cases including the Actos Product Liability Cases Judicial Council Coordinated Proceedings (JCCP 4696) in Los Angeles, California, Heparin Products Liability Litigation, the Consolidated Complex Biological-Medical Products Liability Cases and the Fialuridine Product Liability Cases.

Baum Hedlund lawyers have successfully defeated arguments by drug-makers and the FDA, that cases involving FDA-approved drugs should be federally preempted in a number of cases such as Knipe v. SmithKline Beecham d/b/a GlaxoSmithKline, Tucker v. SmithKline Beecham, Corporation, Collins v. SmithKline Beecham Corporation, Case No. 00762 (Court of Common Pleas, Philadelphia County, March 11, 2008), Steinberg v. SmithKline Beecham Corp. Case No. 1­04­CV­029096 (Santa Clara Sup. Ct., January 25, 2007), Witczak v. Pfizer, 377 F.Supp.2d 726 (D. Minn 2005); Zikis v. Pfizer, Inc., WL 1126909 (N.D. Ill. 2005); Cartwright v. Pfizer, Inc., 369 F.Supp.2d 876 (E.D. Tex. 2005); Miles v. Pfizer, Inc., Case No. 03­731­C (M.D. La. March 31, 2005) (order without opinion); Szybinski v. Pfizer, Inc., Case No. YC 047439 (Los Angeles Sup. Ct. July 12, 2005) (minute order striking FDA Amicus Briefs and denying preemption), and; Motus v. Pfizer, 137 F. Supp. 2d 1085 (C.D. Cal., 2000).

We take pride in creating coalitions of activists, attorneys and Baum Hedlund staff that work together to resolve global problems caused by harmful drugs and products, which no individual could accomplish alone.

Rigorously investigating and litigating the types of devastating drug injury and death cases we handle on a daily basis requires relentless focus and dedication to our clients’ causes. We are tenacious and unflinching when it comes to seeking evidence and have routinely prevailed in both state and federal courts.

Michael L. Baum, Senior managing partner

Baum, Hedlund, Aristei & Goldman has been representing victims of harmful drugs since the late 1980s.

Among the thousands of clients Baum Hedlund has represented in drug injury and wrongful death cases, the firm has represented the widow of 1960’s rock star Del Shannon and the family of comedian Phil Hartman in their antidepressant related death cases.

The drug product liability lawyers at Baum Hedlund have seen the harm caused by these drugs and the lives destroyed and therefore, have gone above and beyond just lawyering to increase awareness of the drugs’ risks. Baum Hedlund lawyers have traveled to Washington, D.C. on numerous occasions, met with members of Congress, the FDA, and Department of Health and Human Services officials. They have also assisted Congressional Investigators in their investigations of drug safety issues and FDA failures.

Baum Hedlund has testified four times before the government regarding the increased risk of suicidality in children, adolescents and adults of all ages. Several of our clients also testified at the FDA’s Psychopharmacologic Drugs Advisory Committee hearings held in 2004 and 2006 regarding antidepressant-induced suicide.  Watch their testimony here.

During our February 2004 testimony before the Food and Drug Administration’s Psychopharmacologic Drugs Advisory Committee, our attorney said, “Put me out of business for the right reasons — warn about these drugs.” Senior partner, Michael Baum, has testified before the Taiwanese government after being called there to share his knowledge about contaminated hemophilia medication exported to foreign countries by U.S. manufacturers.

Baum Hedlund lawyers fight vigorously for the rights of their clients.

Medical Device and Drug Product Liability Cases Handled by Baum Hedlund

  • Actavis Totowa LLC: Digitek injury and death
  • A.H. Robins Company: Dalkon Shield birth control device injuries
  • Alpha Therapeutic: Hemophiliacs infected by HIV contaminated plasma products causing injury and death
  • Armour Pharmaceutical Co.: Hemophiliacs infected by HIV contaminated plasma products causing injury and death
  • Baxter Health Care Corp: Heparin injury and death; Hemophiliacs infected by HIV contaminated plasma products causing injury and death
  • Bayer Corp: Trasylol injury and death; Hemophiliacs infected by HIV contaminated plasma products causing injury and death
  • Boehringer Ingelheim: Zantac and ranitidine cancer
  • Chattem Inc.: Zantac cancer
  • Ciba-Geigy: Ritalin injuries
  • Covidien: Heparin injuries
  • C.R. Bard, Inc.: Kugel Mesh hernia patches
  • Cutter Biologicals: Hemophiliacs infected by HIV contaminated plasma products causing injury and death
  • Davol: Kugel Mesh hernia patches
  • Eli Lilly: Cymbalta withdrawal; Prozac injuries; Prozac suicides and suicide attempts; Fialuridine (FIAU) experimental hepatitis B drug injuries and deaths
  • Forest Labs: Lexapro/Celexa birth defects; Lexapro/Celexa suicides and suicide attempts.  Celexa/Lexapro pediatric use consumer fraud class action
  • GlaxoSmithKline / SmithKline Beecham: Paxil suicides and suicide attempts; Paxil personal injury litigation (MDL-1574); Avandia heart attacks and strokes; Zantac cancer
  • Marion Merrell Dow/Richardson-Merrell: MER/29 (triparanol) birth defects, side effects*
  • Medtronic, Inc., Medtronic Sofamor Danek: Medtronic INFUSE bone graft medical device
  • Merck: Vytorin Consumer Fraud Cases; Vioxx cases;
  • Oclassen: Fialuridine (FIAU) experimental hepatitis B drug injuries and deaths
  • Pfizer: Effexor birth defect; Zoloft birth defects; Zoloft suicides and suicide attempts; Zantac cancer
  • Sanofi: Zantac cancer
  • Schering-Plough: Vytorin Consumer Fraud Cases; Faulty asthma inhalers
  • Sigma Aldrich: Injuries from vaccines containing Thimerosal
  • Solvay Pharmaceuticals, Inc.: Luvox injuries
  • Stryker Biotech, LLC, Stryker Corporation: Calstrux and OP-1 Putty medical devices
  • Takeda Pharmaceuticals: Actos bladder cancer
  • Wyeth Pharmaceuticals, Inc.: Effexor birth defects

*Cases handled by Ronald Goldman before joining Baum Hedlund

*AV® Rating Explanation: Martindale-Hubbell is the facilitator of a peer review rating process. Ratings reflect the confidential opinions of members of the Bar and the Judiciary. Martindale-Hubbell Ratings fall into two categories – legal ability and general ethical standards. “CV, BV and AV are registered certification marks of Reed Elsevier Properties Inc., used in accordance with the Martindale-Hubbell certification procedures, standards and policies.” “An AV® rating reflects an attorney who has reached the heights of professional excellence. He or she has usually practiced law for many years, and is recognized for the highest levels of skill and integrity.”